Small Molecules
23 November 2015
CapGenesis Announces Start of Dosing in an Exploratory Study of CGS-125 for Management of Osteoarthritic Knee Pain23 November 2015
Can-Fite Announces Compelling Pre-Clinical Data on CF102 in the Treatment of Non-Alcoholic Steatohepatitis (NASH)23 November 2015
Alexar Therapeutics, Inc. Initiates Phase IIa Clinical Trial for ALX-101 Topical Gel23 November 2015
CTI BioPharma Initiates Rolling Submission of U.S. New Drug Application for Pacritinib for the Treatment of Patients with Myelofibrosis22 November 2015
CHMP recommends EU approval for UCB’s new drug brivaracetam for people with epilepsy22 November 2015
Novartis receives FDA regular approval for Tafinlar® + Mekinist® to treat aggressive form of melanoma based on long-term survival data22 November 2015
Glaukos Submits IND Application to FDA to Study iDoseTM Travoprost Intraocular Implant in Glaucoma Patients22 November 2015
U.S. FDA Approves Takeda’s NINLARO® (ixazomib), the First and Only Oral Proteasome Inhibitor to Treat Multiple Myeloma20 November 2015
Galapagos initiates Phase 1 First-in-Human study with GLPG1972, receives EU3.5 million milestone from Servier20 November 2015
Portage’s Biohaven announces Phase 1 pharmacokinetic study meets study objectives and supports advancing BHV-0223 and also appoints a CEO19 November 2015
Vitae Pharmaceuticals Announces Positive Top-Line Results From a Phase 1 Multiple Ascending Dose Trial of VTP-4374219 November 2015
Aeterna Zentaris Announces First Patient Enrolled for Confirmatory Phase 3 Trial of Macrilen™ for the evaluation of AGHD19 November 2015
PTC Completes Enrollment of Phase 3 Clinical Trial of Translarna™ for Patients with Cystic Fibrosis18 November 2015
BIND Therapeutics Announces Initiation of Clinical Studies with Accurin AZD2811 in Solid Tumors18 November 2015
Vertex Receives Two EU Approvals for KALYDECO® (ivacaftor) for People with Cystic FibrosisNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports